Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT
- PMID: 31613319
- DOI: 10.1210/en.2019-00556
Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT
Erratum in
-
ERRATUM FOR "WITHDRAWN AS DUPLICATE: Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT".Endocrinology. 2020 Oct 1;161(10):bqaa073. doi: 10.1210/endocr/bqaa073. Endocrinology. 2020. PMID: 32386294 No abstract available.
-
WITHDRAWN AS DUPLICATE: Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT.Endocrinology. 2020 Feb 1;161(2):bqz003. doi: 10.1210/endocr/bqz003. Endocrinology. 2020. PMID: 32639011 No abstract available.
Abstract
Longitudinal observation of pancreatic β-cell mass (BCM) remains challenging because noninvasive techniques for determining BCM in vivo have not been established. Such observations would be useful for the monitoring of type 2 diabetes mellitus, a progressive disease involving loss of pancreatic BCM and function. An indium 111 (111In)-labeled exendin-4 derivative ([Lys12(111In-BnDTPA-Ahx)]exendin-4) targeting the glucagon-like peptide-1 receptor has been developed recently as a promising probe for quantifying the BCM noninvasively. In the present study, we used the 111In-exendin-4 single-photon emission CT/CT (SPECT/CT) technique to investigate the efficacy of DS-8500a, a novel G protein-coupled receptor-119 agonist currently under investigation for type 2 diabetes mellitus treatment in prediabetic db/db mice under dietary restriction. During the 8-week study, the treatment of mice with DS-8500a delayed and attenuated the progression of glucose intolerance compared with mice under dietary restriction alone. 111In-exendin-4 SPECT/CT of db/db mice revealed continuously decreasing radioactive isotope (RI) intensity in the pancreas during the 8-week intervention. DS-8500a attenuated this decrease and preserved pancreatic RI accumulation compared with dietary restriction alone at the end of the observation period. This result was corroborated not only by ex vivo pancreatic analysis using the [Lys12(111In-BnDTPA-Ahx)]exendin-4 probe but also by conventional histological BCM analysis. These results indicate that DS-8500a attenuates the progression of BCM loss beyond that of dietary restriction alone in prediabetic db/db mice. These results have shown that 111In-exendin-4 SPECT/CT will be useful for noninvasive longitudinal investigation of BCM in vivo.
Copyright © 2019 Endocrine Society.
Comment in
-
GPR119 Agonism Revisited: A Novel Target for Increasing β-Cell Mass?Endocrinology. 2020 Feb 1;161(2):bqz018. doi: 10.1210/endocr/bqz018. Endocrinology. 2020. PMID: 32053720 No abstract available.
Similar articles
-
Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using 111In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements.Front Endocrinol (Lausanne). 2022 Sep 29;13:1010825. doi: 10.3389/fendo.2022.1010825. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246910 Free PMC article.
-
DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.J Pharmacol Exp Ther. 2018 Dec;367(3):509-517. doi: 10.1124/jpet.118.250019. Epub 2018 Sep 14. J Pharmacol Exp Ther. 2018. PMID: 30217957
-
Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with 111In-labeled exendin-4.Sci Rep. 2019 Dec 4;9(1):18338. doi: 10.1038/s41598-019-54722-w. Sci Rep. 2019. PMID: 31797889 Free PMC article.
-
Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.Front Endocrinol (Lausanne). 2021 Jun 25;12:714348. doi: 10.3389/fendo.2021.714348. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34248856 Free PMC article. Review.
-
18F-Labeled exendin(9-39).2012 Feb 9 [updated 2012 May 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Feb 9 [updated 2012 May 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22624171 Free Books & Documents. Review.
Cited by
-
Impact of Prevascularization on Immunological Environment and Early Engraftment in Subcutaneous Islet Transplantation.Transplantation. 2024 May 1;108(5):1115-1126. doi: 10.1097/TP.0000000000004909. Epub 2024 Apr 24. Transplantation. 2024. PMID: 38192025 Free PMC article.
-
Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using 111In-exendin-4 SPECT/CT imaging and the perspective of mitochondrial involvements.Front Endocrinol (Lausanne). 2022 Sep 29;13:1010825. doi: 10.3389/fendo.2022.1010825. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246910 Free PMC article.
-
Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.Front Endocrinol (Lausanne). 2022 Jul 12;13:921125. doi: 10.3389/fendo.2022.921125. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909510 Free PMC article.
-
Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.Front Endocrinol (Lausanne). 2022 Mar 31;13:869414. doi: 10.3389/fendo.2022.869414. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432205 Free PMC article. Review.
-
Imaging in experimental models of diabetes.Acta Diabetol. 2022 Feb;59(2):147-161. doi: 10.1007/s00592-021-01826-3. Epub 2021 Nov 15. Acta Diabetol. 2022. PMID: 34779949 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous